Suggestions
John Wilkinson
Partner at Cooley LLP
John Wilkinson is a prominent Partner at Cooley LLP, a global law firm with offices across the United States, Asia, and Europe.1 His practice primarily focuses on the life sciences sector, where he advises pharmaceutical, biotechnology, and medical technology companies on a wide range of matters.2
Expertise and Experience
Wilkinson is recognized as a leading figure in the life sciences and healthcare industry. He specializes in transactional life sciences, leveraging his technical background to assist clients in developing their businesses.2 His expertise extends to complex deals, including acquisitions and licensing agreements in the pharmaceutical and biotech sectors.2
Notable Work
One of Wilkinson's significant achievements includes advising on Jazz Pharmaceuticals' acquisition of Redx Pharma's pan-RAF inhibitor program, a deal valued at up to $206 million.2
Recognition and Accolades
John Wilkinson has received numerous accolades for his work in the life sciences field:
- Ranked in Legal 500 UK for Life Sciences and Healthcare (2022)2
- Listed in Chambers & Partners UK for Transactional Life Sciences2
- Recognized in IAM Patent 1000 and IAM Strategy 3002
- Named as a Global Leader in Who's Who Legal Life Sciences: Transactional (2020)2
- Awarded Transactional Life Sciences Lawyer of the Year (2016) by Who's Who Legal2
Professional Reputation
Wilkinson is highly regarded in the legal and life sciences communities. He has been described as "one of the pioneers of the biotech industry" who is "doing cutting-edge work".2 His colleagues and clients appreciate his intelligence, affability, and consider him a true asset to his firm.3
At Cooley LLP, John Wilkinson continues to play a crucial role in expanding the firm's life sciences partnering and licensing practice, particularly in London.1 His expertise and reputation make him a valuable partner for clients navigating complex transactions and strategic deals in the ever-evolving life sciences sector.
